Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

New England Journal of Medicine

Volumn 344, Issue 19, 2001, Pages 1434-1441

  Neer, Robert M ^a   Arnaud, Claude D ^b   Zanchetta, Jose R ^c   Prince, Richard ^d   Gaich, Gregory A ^e   Reginster, Jean Yves ^f   Hodsman, Anthony B ^g   Eriksen, Erik F ^h   Ish Shalom, Sophia ⁱ   Genant, Harry K ^b   Wang, Ouhong ^e   Mitlak, Bruce H ^e   Mellström, Dan ^j   Oefjord, Erik S ^k   Marcinowska Suchowierska, Ewa ^l   Salmi, Jorma ^m   Mulder, Henk ⁿ   Halse, Johan ^o   Sawicki, Andrzej Z ^p  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Fundación de Investigaciones Metabólicas   (Argentina)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ELI LILLY AND COMPANY   (United States)

^f Polyclinique L Brull   (Belgium)

^g ST JOSEPH S HEALTH CENTRE   (Canada)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ RAMBAM MEDICAL CENTER   (Israel)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

^k Bergen Osteoporosesenter   (Norway)

^l Klinika Chorob Wewnetrznych Kardiol   (Poland)

^m Koskiklinikka   (Finland)

ⁿ Medisch Onderzoekscentrum Gcp   (Netherlands)

^o Betanien Medical Center   (Norway)

^p Warszawskie Centrum Osteoporozy   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PLACEBO;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEADACHE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OSSIFICATION; PATHOLOGIC FRACTURE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTEBRA FRACTURE;

BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; FRACTURES, BONE; HUMANS; INJECTIONS, SUBCUTANEOUS; LUMBAR VERTEBRAE; OSTEOPOROSIS, POSTMENOPAUSAL; SPINAL FRACTURES; TERIPARATIDE;

EID: 0035837553     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200105103441904     Document Type: Article

References (30)

1. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds
2. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone
3. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration
4. Anabolic actions of parathyroid hormone on bone
5. In primates, treatment with PTH (1-34), LY333334, increases bone strength at trabecular bone sites without compromising the strength of cortical bone
6. Vertebral fracture assessment using a semiquantitative technique
7. Comparative calibration without a gold standard
8. Dual X-ray absorptiometry quality control: Comparison of visual examination and process-control charts
9. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol
10. Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients
11. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
12. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
13. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial
14. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
15. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
16. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
17. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
18. Treatment of postmenopausal osteoporosis with transdermal estrogen
19. Prevention of spinal osteoporosis in oophorectomised women
20. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The Prevent Recurrence of Osteoporotic Fractures study
21. Calcitriol treatment is not effective in postmenopausal osteoporosis
22. Treatment of postmenopausal osteoporosis with calcitriol or calcium
23. 3 and calcium to prevent hip fractures in elderly women
24. Annual injection of vitamin D and fractures of aged bones
25. Vitamin D supplementation and fracture incidence in elderly persons: A randomized, placebo-controlled clinical trial
26. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
27. Long-term effects of calcium supplementation on bone loss and fractures in post-menopausal women: A randomized controlled trial
28. Sequential parathyroid hormone/alendronate therapy for osteoporosis - Robbing Peter to pay Paul?
29. Increased risk of malignant diseases after surgery for primary hyperparathyroidism: A nationwide cohort study
30. Survival after the diagnosis of hyperparathyroidism: A population-based study